IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

The Journal of Orthopaedic Translation is a leading peer-reviewed publication dedicated to advancing the field of orthopedics through innovative research and clinical implications. Published by Elsevier and available as an Open Access journal since 2013, it ensures that cutting-edge insights and findings are accessible to a global audience, promoting collaboration and knowledge sharing among researchers, professionals, and students. With an impressive impact factor, the journal has achieved a remarkable Q1 ranking in the categories of Orthopedics and Sports Medicine, placing it in the top 1% of journals in this highly specialized field. As of 2023, it ranks #5 out of 321 in conjunction with a notable 98th percentile achievement in Scopus Ranks, underscoring its reputation for excellence and relevance. Through a focus on both basic and applied research, the Journal of Orthopaedic Translation aims to bridge the gap between laboratory and clinical practice, contributing significantly to the evolving landscape of orthopedic health. Join us in exploring the transformative studies shaping the future of patient outcomes and surgical interventions.

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

Medical Acupuncture is a dedicated peer-reviewed journal that focuses on the intersection of integrative health practices and traditional medicine, particularly emphasizing acupuncture as an evidence-based therapeutic modality. Published by MARY ANN LIEBERT, INC, this journal serves as a pivotal resource for researchers, clinicians, and students in the field of Complementary and Alternative Medicine. With an ISSN of 1933-6586, it has established itself within the academic community, boasting a 2023 Scopus rank of #61 out of 105 in its category, placing it in the 42nd percentile. Although not an open-access journal, it offers a comprehensive platform for exploring the latest developments, clinical applications, and research findings related to acupuncture and its effectiveness in patient care. As it converges years of knowledge from 2008 to 2024, Medical Acupuncture continues to enhance understanding of the therapeutic potential of acupuncture and foster professional discourse in this vital area of health and wellness.

CHINESE JOURNAL OF LASERS-ZHONGGUO JIGUANG is a premier academic publication dedicated to the fields of Atomic and Molecular Physics, Optics, and Electrical and Electronic Engineering. Established in 1991 and published by the esteemed CHINESE LASER PRESS, this journal serves as a crucial platform for researchers, professionals, and students to disseminate significant findings and innovations in laser technology and applications. With its consistent Q3 ranking in the respective categories, the journal is recognized for contributing valuable insights into electronic, optical, and magnetic materials, as well as advancing the understanding of laser phenomena. Although open access options are not available, the journal remains committed to fostering academic discourse and enhancing the visibility of groundbreaking research within and beyond China. The periodical is not only pivotal for those engaged in laser science but also for interdisciplinary studies that intersect with physics and engineering, making it an essential resource for contemporary scholars.

Acupuncture in Medicine, hosted by SAGE PUBLICATIONS LTD, is a prestigious journal dedicated to the growing field of acupuncture and its applications within medicine. With an ISSN of 0964-5284 and an E-ISSN of 1759-9873, this journal serves as an essential resource for clinicians, researchers, and students alike, providing a platform to advance understanding and evidence-based practices in the utilization of acupuncture. Recognized for its impactful contributions, it holds a commendable Q2 ranking in Complementary and Alternative Medicine and a Q3 ranking in both Medicine (miscellaneous) and Neurology (clinical). This journal fosters interdisciplinary dialogue and innovation while adhering to rigorous academic standards, making it a vital reading for anyone interested in the therapeutic potential of acupuncture. With an impressive array of articles published since 1996, Acupuncture in Medicine remains committed to exploring new horizons in integrative medicine, thereby enhancing clinical practice and patient care.

OPTICS AND LASERS IN ENGINEERING, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of optics and laser technology in engineering applications. With a robust ISSN of 0143-8166 and E-ISSN 1873-0302, this journal is positioned within the top quartile (Q1) across several categories, including Atomic and Molecular Physics, Electrical Engineering, and Mechanical Engineering as of 2023, showcasing its prestige and impact in the scientific community. The journal has consistently ranked high in Scopus, notably within the top 10% for Mechanical Engineering and Electronic, Optical, and Magnetic Materials research. Since its inception in 1980, OPTICS AND LASERS IN ENGINEERING has served as a vital platform for disseminating cutting-edge research, fostering innovation and collaboration among researchers, professionals, and academia. Though it does not currently offer Open Access options, its high impact factor and selective publication process ensure that articles reach a wide audience while maintaining rigorous academic standards. Researchers and students alike are encouraged to engage with this influential journal to contribute to and stay abreast of advancements in optical technologies and their engineering applications.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

LASERS IN MEDICAL SCIENCE is a prestigious journal published by Springer London Ltd, dedicated to advancing the field of medical laser applications. With an ISSN of 0268-8921 and an E-ISSN of 1435-604X, this journal serves as a vital platform for the dissemination of innovative research and clinical advancements in dermatology and surgery. Recognized within the 2023 Q2 category for both dermatology and surgery, it holds significant prominence, ranking amidst the top quartiles of the respective fields. The journal's Scopus rankings further emphasize its influence, with a percentile standing of 80th in medicine surgery and 75th in medicine dermatology. Although it does not offer open access, its content is essential for researchers, practitioners, and students seeking the latest insights and evidence-based practices in the science of lasers for medical applications, thus contributing to improved patient outcomes. Operating from its UK base at 236 Grays Inn Rd, 6th Floor, London WC1X 8HL, LASERS IN MEDICAL SCIENCE continues to push the frontiers of knowledge in laser medicine from its inception in 1986 through to 2024.

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.